Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Schimmack

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Surgery|September 25, 2025
Indications and outcome of surgery for small nonfunctioning pancreatic neuroendocrine neoplasms (≤2 cm)Fabiola A Bechtiger, Anna Nießen, Ulf Hinz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 1, 2014
Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signalingSimon Schimmack, Andrew Taylor, Ben Lawrence, et al.
Journal of Cancer|March 5, 2020
Actinin-4 splice variant - a complementary diagnostic and prognostic marker of pancreatic neuroendocrine neoplasmsXiaojun Xu, Kazufumi Honda, Nami Miura, et al.
Histopathology|August 21, 2015
Differential nuclear ATRX expression in sarcomasChristian Koelsche, Marcus Renner, Pascal Johann, et al.
Neuroendocrinology|April 25, 2019
Placenta-Specific 8 Is Overexpressed and Regulates Cell Proliferation in Low-Grade Human Pancreatic Neuroendocrine TumorsMarina Tatura, Harald Schmidt, Mikail Haijat, et al.
Gastroenterology|November 26, 2009
Chronic pancreatitis is associated with disease-specific regulatory T-cell responsesHubertus Schmitz-Winnenthal, Dong-Ho Kim Pietsch, Simon Schimmack, et al.
Neuroendocrinology|August 3, 2021
International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine TumorsCharlotte M Heidsma, Stijn van Roessel, Susan van Dieren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue SarcomaPriya Chudasama, Marcus Renner, Melanie Straub, et al.
Oncoimmunology|July 3, 2015
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trialFriedrich H Schmitz-Winnenthal, Nicolas Hohmann, Andreas G Niethammer, et al.
Nature Communications|January 12, 2018
Integrative genomic and transcriptomic analysis of leiomyosarcomaPriya Chudasama, Sadaf S Mughal, Mathijs A Sanders, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Surgery|September 25, 2025
Indications and outcome of surgery for small nonfunctioning pancreatic neuroendocrine neoplasms (≤2 cm)Fabiola A Bechtiger, Anna Nießen, Ulf Hinz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 1, 2014
Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signalingSimon Schimmack, Andrew Taylor, Ben Lawrence, et al.
Journal of Cancer|March 5, 2020
Actinin-4 splice variant - a complementary diagnostic and prognostic marker of pancreatic neuroendocrine neoplasmsXiaojun Xu, Kazufumi Honda, Nami Miura, et al.
Histopathology|August 21, 2015
Differential nuclear ATRX expression in sarcomasChristian Koelsche, Marcus Renner, Pascal Johann, et al.
Neuroendocrinology|April 25, 2019
Placenta-Specific 8 Is Overexpressed and Regulates Cell Proliferation in Low-Grade Human Pancreatic Neuroendocrine TumorsMarina Tatura, Harald Schmidt, Mikail Haijat, et al.
Gastroenterology|November 26, 2009
Chronic pancreatitis is associated with disease-specific regulatory T-cell responsesHubertus Schmitz-Winnenthal, Dong-Ho Kim Pietsch, Simon Schimmack, et al.
Neuroendocrinology|August 3, 2021
International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine TumorsCharlotte M Heidsma, Stijn van Roessel, Susan van Dieren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue SarcomaPriya Chudasama, Marcus Renner, Melanie Straub, et al.
Oncoimmunology|July 3, 2015
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trialFriedrich H Schmitz-Winnenthal, Nicolas Hohmann, Andreas G Niethammer, et al.
Nature Communications|January 12, 2018
Integrative genomic and transcriptomic analysis of leiomyosarcomaPriya Chudasama, Sadaf S Mughal, Mathijs A Sanders, et al.
Pageof 4